These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38250621)

  • 1. Testing the limits of multiplex respiratory virus assays for SARS-CoV-2 at high cycle threshold values: Comparative performance of cobas 6800/8800 SARS-CoV-2 & Influenza A/B, Xpert Xpress SARS-CoV-2/Flu/RSV, and cobas Liat SARS-CoV-2 & Influenza A/B.
    Matic N; Lawson T; Ritchie G; Lowe CF; Romney MG
    J Assoc Med Microbiol Infect Dis Can; 2024 Jan; 8(4):328-335. PubMed ID: 38250621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of Two Automated Multiplex RT-PCR Tests for Rapid Detection of Influenza and Respiratory Syncytial Viruses.
    Hur KH; Sung H; Kim MN
    Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus.
    Zhen W; Manji R; Smith E; Wuitschick J; Lucic D; Berry GJ
    Microbiol Spectr; 2022 Feb; 10(1):e0109021. PubMed ID: 35107357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the analytical and clinical performance of two RT-PCR based point-of-care tests; Cepheid Xpert® Xpress CoV-2/Flu/RSV plus and SD BioSensor STANDARD™ M10 Flu/RSV/SARS-CoV-2.
    Jensen CB; Schneider UV; Madsen TV; Nielsen XC; Ma CMG; Severinsen JK; Hoegh AM; Botnen AB; Trebbien R; Lisby JG
    J Clin Virol; 2024 Jun; 172():105674. PubMed ID: 38643722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens.
    Leung EC; Chow VC; Lee MK; Tang KP; Li DK; Lai RW
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33436456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.
    Wolters F; Grünberg M; Huber M; Kessler HH; Prüller F; Saleh L; Fébreau C; Rahamat-Langendoen J; Thibault V; Melchers WJG
    J Med Virol; 2021 Oct; 93(10):5798-5804. PubMed ID: 34050951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Evaluation of the Xpert
    Noble LD; Scott LE; Munir R; Du Plessis M; Steegen K; Hans L; Marokane P; Da Silva P; Stevens WS
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Seegene Allplex™ RV master assay for one-step simultaneous detection of eight respiratory viruses in nasopharyngeal specimens.
    Mdunyelwa A; Seema C; Mabaso A; Mlambo K; Mtsweni M; Maphanga M; Rammutla E; Tempelman HA; Umunnakwe CN
    J Virol Methods; 2025 Jan; 331():115042. PubMed ID: 39384158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children.
    Banerjee D; Kanwar N; Hassan F; Essmyer C; Selvarangan R
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30185508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva.
    Tsang HF; Leung WMS; Chan LWC; Cho WCS; Wong SCC
    Expert Rev Mol Diagn; 2021 May; 21(5):515-518. PubMed ID: 33906571
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative Evaluation of a Standard M10 Assay with Xpert Xpress for the Rapid Molecular Diagnosis of SARS-CoV-2, Influenza A/B Virus, and Respiratory Syncytial Virus.
    Abdullah A; Sam IC; Ong YJ; Theo CH; Pukhari MH; Chan YF
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A/B assay: A systematic review and meta-analysis.
    Chang E; Jeon K; Lee N; Park MJ; Song W; Kim HS; Kim HS; Kim JS; Kim J; Jeong S
    J Clin Virol; 2024 Oct; 174():105706. PubMed ID: 38908267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens.
    Ho YII; Wong AH; Lai RWM
    J Med Microbiol; 2018 Nov; 67(11):1576-1580. PubMed ID: 30207514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test.
    Sluimer J; Goderski G; van den Brink S; Broeders M; Rahamat-Langendoen J; Then E; Wijsman L; Wolters F; van de Bovenkamp J; Melchers WJ; Meijer A
    J Clin Virol Plus; 2021 Dec; 1(4):100042. PubMed ID: 35262024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Xpert Xpress CoV-2/Flu/RSV Plus Kit: A Glance at RSV Infection in Adults and Coinfection Rate.
    Alkharsah KR
    Saudi J Med Med Sci; 2024; 12(2):182-187. PubMed ID: 38764565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection.
    Schmidt RLJ; Simon A; Popow-Kraupp T; Laggner A; Haslacher H; Fritzer-Szekeres M; Redlberger-Fritz M; Mayer FJ
    Clin Microbiol Infect; 2019 Aug; 25(8):1032-1037. PubMed ID: 30583060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay.
    Domnich A; Bruzzone B; Trombetta CS; De Pace V; Ricucci V; Varesano S; Garzillo G; Ogliastro M; Orsi A; Icardi G
    J Clin Virol; 2023 Apr; 161():105402. PubMed ID: 36805601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the analytical sensitivity and clinical performance of two cobas SARS-CoV-2 tests based on high-throughput and point-of-care systems.
    Lin TH; Bui NN; Chang YC; Hsu LY; Su YD; Chang CM; Hong WA; Le UNP; Huang SH; Lin CW
    Biomedicine (Taipei); 2022; 12(2):40-46. PubMed ID: 35836977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.